4'-deoxydoxorubicinol has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldini, E; Bocci, G; Conte, PF; Danesi, R; Del Tacca, M; Di Paolo, A; Fogli, S; Gennari, A; Innocenti, F; Salvadori, B | 1 |
| Bastholt, L; Dalmark, M; Gjedde, SB; Jakobsen, P; Mouridsen, HT; Nielsen, OS; Petersen, D; Pfeiffer, P; Rose, C; Sandberg, E | 1 |
2 trial(s) available for 4'-deoxydoxorubicinol and Breast Neoplasms
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Interactions; Epirubicin; Female; Glycerol; Humans; In Vitro Techniques; Infusions, Intravenous; Middle Aged; Paclitaxel | 2002 |
A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement.
Topics: Bone Marrow; Breast Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Female; Humans; Infusions, Intravenous; Leukocyte Count; Prognosis; Regression Analysis; Time Factors | 1991 |